Passive protection studies in mice with monoclonal antibodies directed against the non-structural protein NS3 of dengue 1 virus

References

1. Bhamarapravati N. 1989; Live attenuated dengue vaccine development in Thailand. In Symposium on Dengue Fever Taipei, Taiwan:
   [Google Scholar]
2. Bhamarapravati N., Yoksan S., Chanyaniyayothin T., Angsubphakorn S., Bunyaratvej A. 1987; Immunization with a live attenuated dengue 2 virus candidate vaccine (16681-PDK 53): clinical, immunological and biological responses in adult volunteers. Bulletin of the World Health Organization 65:189–195
   [Google Scholar]
3. Clarke D. H., Casals J. 1958; Techniques for hemagglutination and hemagglutination-inhibition with arthropod-borne viruses. American Journal of Tropical Medicine and Hygiene 7:561–573
   [Google Scholar]
4. Deubel V., Kinney K. M., Trent D. W. 1988; Nucleotide sequence and deduced amino acid sequence of the nonstructural proteins of dengue type 2 virus, Jamaica genotype: comparative analysis of the full length genome. Virology 165:234–244
   [Google Scholar]
5. Dieckmann C. L., Tzagoloff A. 1985; Assembly of the mitochondrial membrane system. Journal of Biological Chemistry 260:1513–1530
   [Google Scholar]
6. Earley E. M., Osterling M. C. 1985; Fusion of mouse-mouse cells to produce hybridomas secreting monoclonal antibodies. Journal of Tissue Culture Methods 9:141–146
   [Google Scholar]
7. Falconar A. K. I., Young P. R. 1989; Functional analysis of a panel of monoclonal antibodies generated against the nonstructural glycoprotein, NS1 of dengue type 2 virus (PR1590). In 2nd International Symposium on Positive Strand RNA Viruses Vienna, Austria:
   [Google Scholar]
8. Gould E. A., Buckley A., Barrett A. D. T., Cammack N. 1986; Neutralizing (54K) and non-neutralizing (54K and 48K) monoclonal antibodies against structural and non-structural yellow fever virus proteins confer immunity in mice. Journal of General Virology 67:591–595
   [Google Scholar]
9. Halstead S. B. 1988; Pathogenesis of dengue: challenges to molecular biology. Science 239:476–481
   [Google Scholar]
10. Henchal E. A., Henchal L. S., Schlesinger J. J. 1988; Synergistic interactions of anti-NSl monoclonal antibodies protect passively immunized mice from lethal challenge with dengue 2 virus. Journal of General Virology 69:2101–2107
    [Google Scholar]
11. Hsiung G. D., Fong C. K. Y. 1982; Methods commonly used in virus isolation and detection. In Diagnostic Virology, 3rd edn. pp. 42–49 New Haven & London: Yale University Press;
    [Google Scholar]
12. Kurane I., Bukowski J. F., Lai C.-J., Brinton M., Bray M., Falgout B., Zhao B., Ennis F. A. 1989; Dengue virus-specific human cytotoxic T lymphocytes (CTL). In 2nd International Symposium on Positive Strand RNA Viruses Vienna, Austria:
    [Google Scholar]
13. Mackow E., Makino Y., Zhao B., Zhang Y.-M., Markoff L., Buckler-White A., Guiler M., Chanock R., Lai C.-J. 1987; The nucleotide sequence of dengue type 4 virus: analysis of genes coding for nonstructural proteins. Virology 159:217–228
    [Google Scholar]
14. Preugschat F., Strauss J. H. 1989; In vivo processing of dengue 2 virus nonstructural proteins. In 2nd International Symposium on Positive Strand RNA Viruses Vienna, Austria:
    [Google Scholar]
15. Reed L. J., Muench H. 1938; A simple method of estimating fifty percent endpoints. American Journal of Tropical Medicine and Hygiene 27:493–497
    [Google Scholar]
16. Rice C. M., Lenches E. M., Eddy S. R., Shin S. J., Sheets R. L., Strauss J. H. 1985; Nucleotide sequence of yellow fever virus: implications for flavivirus gene expression and evolution. Science 229:726–733
    [Google Scholar]
17. Rice C. M., Strauss E. G., Strauss J. H. 1986; Structure of the flavivirus genome. In Togaviridae and Flaviviridae pp. 279–326 Schlesinger M., Schlesinger S. Edited by New York: Plenum Press;
    [Google Scholar]
18. Schlesinger J. J., Brandriss M. W., Walsh E. E. 1985; Protection against 17D yellow fever encephalitis in mice by passive transfer of monoclonal antibodies to the nonstructural glycoprotein gp48 and by active immunization with gp48. Journal of Immunology 135:2805–2809
    [Google Scholar]
19. Schlesinger J. J., Brandriss M. W., Walsh E. E. 1987; Protection of mice against dengue 2 virus encephalitis by immunization with the dengue 2 virus non-structural glycoprotein NS1. Journal of General Virology 68:853–857
    [Google Scholar]
20. Smith G. C. E., Westgarth D. R. 1957; The use of survival time in the analysis of neutralisation tests for serum antibody surveys. Journal of Hygiene 55:224–238
    [Google Scholar]
21. Westaway E. G. 1977; Strategy of the flavivirus genome: evidence for multiple internal initiation of proteins specified by Kunjin virus in mammalian cells. Virology 80:320–335
    [Google Scholar]
22. Zhang Y. M., Falgout B., Bray M., Dubois D. R., Eckels K. H., Chanock R. M., Lai C. J. 1989; Use of subunit proteins and recombinant vaccinia viruses expressing nonstructural protein NS1 for immunisation against dengue virus infection. In WHO Programme for Vaccine Development. Steering Committee on Dengue. Scientific Meeting: Development of Flavivirus Vaccines for Dengue and Japanese Encephalitis Vienna, Austria:
    [Google Scholar]